Literature DB >> 33104965

Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.

Bo Chen1,2, Zhongyan Hua1,2, Xiuni Qin1,2, Zhijie Li3,4.   

Abstract

Neuroblastomas (NB) are childhood malignant tumors originating in the sympathetic nervous system. MicroRNAs (miRNAs) play an essential regulatory role in tumorigenesis and development. In this study, NB miRNA and mRNA expression profile data in the Gene Expression Omnibus database were used to screen for differentially expressed miRNAs (DEMs) and genes (DEGs). We used the miRTarBase and miRSystem databases to predict the target genes of the DEMs, and we selected target genes that overlapped with the DEGs as candidate genes for further study. Annotations, visualization, and the DAVID database were used to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis on the candidate genes. Additionally, the protein-protein interaction (PPI) network and miRNA-mRNA regulatory network were constructed and visualized using the STRING database and Cytoscape, and the hub modules were analyzed for function and pathway enrichment using the DAVID database and BiNGO plug-in. 107 DEMs and 1139 DEGs were identified from the miRNA and mRNA chips, respectively. 4390 overlapping target genes were identified using the two databases, and 405 candidate genes which intersected with the DEGs were selected. These candidate genes were enriched in 363 GO terms and 24 KEGG pathways. By constructing a PPI network and a miRNA-mRNA regulatory network, three hub miRNAs (hsa-miR-30e-5p, hsa-miR-15a, and hsa-miR-16) were identified. The target genes of the hub miRNAs were significantly enriched in the following pathways: microRNAs in cancer, the PI3K-Akt signaling pathway, pathways in cancer, the p53 signaling pathway, and the cell cycle. In summary, our results have identified candidate genes and pathways related to the underlying molecular mechanism of NB. These findings provide a new perspective for NB research and treatment.

Entities:  

Keywords:  Bioinformatics analysis; Microarray; Neuroblastoma; miRNA–mRNA regulatory network

Mesh:

Substances:

Year:  2020        PMID: 33104965     DOI: 10.1007/s11064-020-03155-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  65 in total

1.  Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?

Authors:  Dana L Casey; Ken L Pitter; Brian H Kushner; Nai-Kong V Cheung; Shakeel Modak; Michael P LaQuaglia; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-01-09       Impact factor: 7.038

Review 2.  Pediatrics: diagnosis of neuroblastoma.

Authors:  Susan E Sharp; Michael J Gelfand; Barry L Shulkin
Journal:  Semin Nucl Med       Date:  2011-09       Impact factor: 4.446

3.  Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.

Authors:  Jennifer E Gains; Neil J Sebire; Veronica Moroz; Keith Wheatley; Mark N Gaze
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-17       Impact factor: 9.236

4.  Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

Authors:  Malcolm A Smith; Nita L Seibel; Sean F Altekruse; Lynn A G Ries; Danielle L Melbert; Maura O'Leary; Franklin O Smith; Gregory H Reaman
Journal:  J Clin Oncol       Date:  2010-04-19       Impact factor: 44.544

5.  Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.

Authors:  Susan G Kreissman; Robert C Seeger; Katherine K Matthay; Wendy B London; Richard Sposto; Stephan A Grupp; Daphne A Haas-Kogan; Michael P Laquaglia; Alice L Yu; Lisa Diller; Allen Buxton; Julie R Park; Susan L Cohn; John M Maris; C Patrick Reynolds; Judith G Villablanca
Journal:  Lancet Oncol       Date:  2013-07-25       Impact factor: 41.316

Review 6.  The prenatal origins of cancer.

Authors:  Glenn M Marshall; Daniel R Carter; Belamy B Cheung; Tao Liu; Marion K Mateos; Justin G Meyerowitz; William A Weiss
Journal:  Nat Rev Cancer       Date:  2014-03-06       Impact factor: 60.716

7.  Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors.

Authors:  Maja Olsson; Stephan Beck; Per Kogner; Tommy Martinsson; Helena Carén
Journal:  Epigenetics       Date:  2016-01-19       Impact factor: 4.528

8.  International incidence of childhood cancer, 2001-10: a population-based registry study.

Authors:  Eva Steliarova-Foucher; Murielle Colombet; Lynn A G Ries; Florencia Moreno; Anastasia Dolya; Freddie Bray; Peter Hesseling; Hee Young Shin; Charles A Stiller
Journal:  Lancet Oncol       Date:  2017-04-11       Impact factor: 41.316

Review 9.  Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma.

Authors:  Harriet E D Southgate; Lindi Chen; Nicola J Curtin; Deborah A Tweddle
Journal:  Front Oncol       Date:  2020-04-03       Impact factor: 6.244

10.  Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: A Mendelian randomization study.

Authors:  Nikos Papadimitriou; Niki Dimou; Dipender Gill; Ioanna Tzoulaki; Neil Murphy; Elio Riboli; Sarah J Lewis; Richard M Martin; Marc J Gunter; Konstantinos K Tsilidis
Journal:  Int J Cancer       Date:  2020-08-25       Impact factor: 7.396

View more
  5 in total

1.  Antioxidant Effects and Potential Molecular Mechanism of Action of Limonium aureum Extract Based on Systematic Network Pharmacology.

Authors:  Zhen Yang; Yanan Mo; Feng Cheng; Hongjuan Zhang; Ruofeng Shang; Xuehong Wang; Jianping Liang; Yu Liu; Baocheng Hao
Journal:  Front Vet Sci       Date:  2022-01-05

2.  A regulatory miRNA-mRNA network is associated with transplantation response in acute kidney injury.

Authors:  Duan Guo; Yu Fan; Ji-Rong Yue; Tao Lin
Journal:  Hum Genomics       Date:  2021-12-09       Impact factor: 4.639

3.  Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis.

Authors:  Chirasmita Nayak; Sanjeev Kumar Singh
Journal:  ACS Omega       Date:  2022-06-22

4.  Development of cancer prognostic signature based on pan-cancer proteomics.

Authors:  Weiguo Huang; Jianhui Chen; Wanqing Weng; Yukai Xiang; Hongqi Shi; Yunfeng Shan
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

5.  Long Noncoding RNA LINC01410 Suppresses Tumorigenesis and Enhances Radiosensitivity in Neuroblastoma Cells Through Regulating miR-545-3p/HK2 Axis.

Authors:  Liping Mou; Lili Wang; Shaoming Zhang; Qinghua Wang
Journal:  Onco Targets Ther       Date:  2021-05-18       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.